Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Clark A. J., Adeniyi-Jones R. O., Knight G., Leiper J. M., Wiles P. G., Jones R. H., Keen H., MacCuish A. C., Ward J. D., Watkins P. J. Biosynthetic human insulin in the treatment of diabetes. A double-blind crossover trial in established diabetic patients. Lancet. 1982 Aug 14;2(8294):354–357. doi: 10.1016/s0140-6736(82)90548-7. [DOI] [PubMed] [Google Scholar]
- Ebihara A., Kondo K., Ohashi K., Kosaka K., Kuzuya T., Matsuda A. Comparative clinical pharmacology of human insulin (Novo) and porcine insulin in normal subjects. Diabetes Care. 1983 Mar-Apr;6 (Suppl 1):17–22. [PubMed] [Google Scholar]
- Fineberg S. E., Galloway J. A., Fineberg N. S., Rathbun M. J., Hufferd S. Immunogenicity of recombinant DNA human insulin. Diabetologia. 1983 Dec;25(6):465–469. doi: 10.1007/BF00284452. [DOI] [PubMed] [Google Scholar]
- Hildebrandt P., Berger A., Vølund A., Kühl C. The subcutaneous absorption of human and bovine ultralente insulin formulations. Diabet Med. 1985 Sep;2(5):355–359. doi: 10.1111/j.1464-5491.1985.tb00650.x. [DOI] [PubMed] [Google Scholar]
- Home P. D., Alberti K. G. Human insulin. Clin Endocrinol Metab. 1982 Jul;11(2):453–483. doi: 10.1016/s0300-595x(82)80024-8. [DOI] [PubMed] [Google Scholar]
- Home P. D., Mann N. P., Hutchison A. S., Park R., Walford S., Murphy M., Reeves W. G. A fifteen-month double-blind cross-over study of the efficacy and antigenicity of human and pork insulins. Diabet Med. 1984 Jul;1(2):93–98. doi: 10.1111/j.1464-5491.1984.tb01936.x. [DOI] [PubMed] [Google Scholar]
- Kemmer F. W., Sonnenberg G., Cüppers H. J., Berger M. Absorption kinetics of semisynthetic human insulin and biosynthetic (recombinant DNA) human insulin. Diabetes Care. 1982 Nov-Dec;5 (Suppl 2):23–28. doi: 10.2337/diacare.5.2.s23. [DOI] [PubMed] [Google Scholar]
- Mann N. P., Johnston D. I., Reeves W. G., Murphy M. A. Human insulin and porcine insulin in the treatment of diabetic children: comparison of metabolic control and insulin antibody production. Br Med J (Clin Res Ed) 1983 Nov 26;287(6405):1580–1582. doi: 10.1136/bmj.287.6405.1580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Owens D. R., Jones I. R., Birtwell A. J., Burge C. T., Luzio S., Davies C. J., Heyburn P., Heding L. G. Study of porcine and human isophane (NPH) insulins in normal subjects. Diabetologia. 1984 Apr;26(4):261–265. doi: 10.1007/BF00283647. [DOI] [PubMed] [Google Scholar]
- Owens D. R., Jones M. K., Hayes T. M., Heding L. G., Alberti K. G., Home P. D., Burrin J. M., Newcombe R. G. Human insulin: study of safety and efficacy in man. Br Med J (Clin Res Ed) 1981 Apr 18;282(6272):1264–1266. doi: 10.1136/bmj.282.6272.1264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pickup J. C., Bilous R. W., Viberti G. C., Keen H., Jarrett R. J., Glynne A., Cauldwell J., Root M., Rubenstein A. H. Plasma insulin and C-peptide after subcutaneous and intravenous administration of human insulin (recombinant DNA) and purified porcine insulin in healthy men. Diabetes Care. 1982 Nov-Dec;5 (Suppl 2):29–34. doi: 10.2337/diacare.5.2.s29. [DOI] [PubMed] [Google Scholar]
- Pramming S., Lauritzen T., Thorsteinsson B., Johansen K., Binder C. Absorption of soluble and isophane semi-synthetic human and porcine insulin in insulin-dependent diabetic subjects. Acta Endocrinol (Copenh) 1984 Feb;105(2):215–220. doi: 10.1530/acta.0.1050215. [DOI] [PubMed] [Google Scholar]